ID   MNZTASi001-A
AC   CVCL_B5IS
SY   MS_0004; MS_0004.2; MS 0004-iPSC clone 2
DR   BioSamples; SAMEA112762629
DR   hPSCreg; MNZTASi001-A
DR   Wikidata; Q110433060
RX   PubMed=34678664;
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34678664
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 30,31
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=34678664; DOI=10.1016/j.scr.2021.102568;
RA   Mehta A., Lu P., Taylor B.V., Charlesworth J.C., Cook A.L., Burdon K.P.,
RA   Hewitt A.W., Young K.M.;
RT   "Generation of MNZTASi001-A, a human pluripotent stem cell line from a
RT   person with primary progressive multiple sclerosis.";
RL   Stem Cell Res. 57:102568-102568(2021).
//